Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections
- PMID: 20100100
- DOI: 10.3109/09286580903450346
Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections
Abstract
Purpose: To present a comprehensive estimate of the total number of people with visual impairment in the adult Japanese population by age, gender, severity and cause, and to estimate future prevalence based on population projections and expected demographic changes.
Methods: Definitions of visual impairment used in this study were based on the United States criteria. Total visual impairment was calculated as the sum of low vision and blindness. The prevalence estimates were based on input from a number of Japanese epidemiological surveys, census material and official population projections.
Results: There were an estimated 1.64 million people with visual impairment in 2007 in Japan. Of these, 187,800 were estimated to be blind. The prevalence of visual impairment in Japan increased with age and half of the people with visual impairment were aged 70 years or older. The leading causes of visual impairment in Japan were glaucoma (24.3%), diabetic retinopathy (20.6%), degenerative myopia (12.2%), age-related macular degeneration (10.9%), and cataract (7.2%). These five major causes comprised three-quarters of all visual impairment. The prevalence of visual impairment was projected to increase from 1.3% of the population in 2007 to 2.0% by 2050.
Conclusions: This comprehensive study presents the prevalence of total visual impairment in the adult Japanese population. The projected increases in the prevalence of visual impairment over time reflect the demographic changes of a declining and aging Japanese population. These projections highlight that the burden of disease due to visual impairment and imposed on society is likely to increase.
Similar articles
-
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2. Ophthalmology. 2006. PMID: 16647133
-
Causes and prevalence of visual impairment among adults in the United States.Arch Ophthalmol. 2004 Apr;122(4):477-85. doi: 10.1001/archopht.122.4.477. Arch Ophthalmol. 2004. PMID: 15078664
-
Prevalence and Causes of Visual Impairment in a Chinese Adult Population: The Taizhou Eye Study.Ophthalmology. 2015 Jul;122(7):1480-8. doi: 10.1016/j.ophtha.2015.03.022. Epub 2015 May 16. Ophthalmology. 2015. PMID: 25986897
-
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275950 Free PMC article.
-
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1. Lancet Glob Health. 2021. PMID: 33275949 Free PMC article.
Cited by
-
Investigation of Macular Choroidal Thickness and Blood Flow Change by Optical Coherence Tomography Angiography After Posterior Scleral Reinforcement.Front Med (Lausanne). 2021 Apr 29;8:658259. doi: 10.3389/fmed.2021.658259. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34017847 Free PMC article.
-
Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography.Am J Ophthalmol. 2011 Oct;152(4):663-8. doi: 10.1016/j.ajo.2011.03.008. Epub 2011 Jun 25. Am J Ophthalmol. 2011. PMID: 21708378 Free PMC article.
-
Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems.Nutrients. 2024 May 30;16(11):1715. doi: 10.3390/nu16111715. Nutrients. 2024. PMID: 38892648 Free PMC article. Review.
-
Result of intravitreal aflibercept injection for myopic choroidal neovascularization.BMC Ophthalmol. 2021 Sep 22;21(1):342. doi: 10.1186/s12886-021-02088-x. BMC Ophthalmol. 2021. PMID: 34551746 Free PMC article.
-
Reconsideration of the most appropriate criterion in the lowest classification of vision disability in Japan.Jpn J Ophthalmol. 2011 Nov;55(6):651-9. doi: 10.1007/s10384-011-0081-8. Epub 2011 Aug 24. Jpn J Ophthalmol. 2011. PMID: 21863220
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical